Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date COVID-19 Vaccine Patient Education: Addressing Vaccine HesitancyRelease Date:Education Vaccines All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Quality Improvement Grants to Support the Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease Canada Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) ResearchRelease Date:Research Rare Disease All Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease All 2021 Growth Hormone Research (United States)Release Date:Research Rare Disease USA AcromegalyRelease Date:Research Rare Disease USA Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates 2021 Global ANGPTL3 ASPIRERelease Date:Research Internal Medicine All Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan)Release Date:Fellowship Inflammation & Immunology All Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease USA Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa)Release Date:Education Inflammation & Immunology All PCF-Pfizer Health Equity Challenge AwardsResearch Oncology All Shared Decision Making Including Financial Cost and Cancer TreatmentRelease Date:Education Oncology Japan Employment Support / Lung CancerRelease Date:Education Oncology Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Early Identification and Diagnosis of Axial SpondyloarthritisRelease Date:Education Inflammation & Immunology USA BRAF-mutant melanoma: treatment selection and side effect managementRelease Date:Education Oncology Canada, USA Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic EmbolismRelease Date:Quality Improvement Internal Medicine Japan Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Education for Improving Appropriate Diagnosis and Treatment for Venous ThromboembolismRelease Date:Education Internal Medicine Japan Education and Support for Patients with Locally-Advanced or Metastatic Bladder CancerRelease Date:Partner: Merck KGaA, Darmstadt, Germany and EMD SeronoEducation Oncology USA Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology Canada, USA Management of Patients with BRAF-mutant metastatic colorectal cancerRelease Date:Education Oncology Canada, USA Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare DiseaseRelease Date:Quality Improvement Rare Disease All Promotion of Smoking Cessation Treatment in General PracticeRelease Date:Education Internal Medicine Japan 2021 Growth Hormone Research (All countries except for the United States)Release Date:Research Rare Disease All Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis PainEducation Internal Medicine All NSCLC Therapy Management for Optimal OutcomesRelease Date:Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom Clinical Research Capability DevelopmentRelease Date:Education Internal Medicine China Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease China Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Improve the care of patients living with metastatic breast cancerQuality Improvement Oncology Canada Topical Hemostasis in Minimally Invasive SurgeryRelease Date:Education Hospital USA Advances in Immuno-Oncology Therapy in Urothelial CancerRelease Date:Education Oncology Japan IBD Fellow Training in USRelease Date:Education Inflammation & Immunology USA Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal CancerQuality Improvement Oncology USA Imaging Diagnostics for Differentiating Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Improving Treatment Environment for Chronic Myeloid Leukemia (CML)Release Date:Education Oncology Japan Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown CauseRelease Date:Education Rare Disease Japan Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and CaregiversRelease Date:Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom Atrial Fibrillation and Venous Thromboembolism (excluding United States)Education Internal Medicine All China Breast Cancer Landscape – Educational Needs AssessmentRelease Date:Education Oncology China